Related references
Note: Only part of the references are listed.Cell-Specific Targeting Strategies for Electroporation-Mediated Gene Delivery in Cells and Animals
David A. Dean
JOURNAL OF MEMBRANE BIOLOGY (2013)
Performance of High Quality Minicircle DNA for In Vitro and In Vivo Gene Transfer
Dennis Kobelt et al.
MOLECULAR BIOTECHNOLOGY (2013)
A Mini-intronic Plasmid (MIP): A Novel Robust Transgene Expression Vector In Vivo and In Vitro
Jiamiao Lu et al.
MOLECULAR THERAPY (2013)
Minicircle DNA Vectors Achieve Sustained Expression Reflected by Active Chromatin and Transcriptional Level
Lia E. Gracey Maniar et al.
MOLECULAR THERAPY (2013)
Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses
Wynette M. Dietz et al.
MOLECULAR THERAPY (2013)
Marker-free plasmids for biotechnological applications - implications and perspectives
Pedro H. Oliveira et al.
TRENDS IN BIOTECHNOLOGY (2013)
Efficient Sleeping Beauty DNA Transposition From DNA Minicircles
Nynne Sharma et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
Kathleen A. Cashman et al.
VACCINES (2013)
Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines
F. Cramer et al.
CANCER GENE THERAPY (2012)
Supercoiled Minivector DNA resists shear forces associated with gene therapy delivery
D. J. Catanese et al.
GENE THERAPY (2012)
The Extragenic Spacer Length Between the 5′ and 3′ Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors
Jiamiao Lu et al.
MOLECULAR THERAPY (2012)
Clinical Applications of DNA Vaccines: Current Progress
Bernadette Ferraro et al.
CLINICAL INFECTIOUS DISEASES (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
Scaffold/Matrix Attached Region-Based Nonviral Episomal Vectors
Claudia Hagedorn et al.
HUMAN GENE THERAPY (2011)
Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver
Orestis Argyros et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Minicircle DNA-based Gene Therapy Coupled With Immune Modulation Permits Long-term Expression of α-L-Iduronidase in Mice With Mucopolysaccharidosis Type I
Mark J. Osborn et al.
MOLECULAR THERAPY (2011)
pEPito: a significantly improved non-viral episomal expression vector for mammalian cells
Rudolf Haase et al.
BMC BIOTECHNOLOGY (2010)
CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Minicircle Performance Depending on S/MAR-Nuclear Matrix Interactions
Sandra Broll et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
A robust system for production of minicircle DNA vectors
Mark A. Kay et al.
NATURE BIOTECHNOLOGY (2010)
A nonviral minicircle vector for deriving human iPS cells
Fangjun Jia et al.
NATURE METHODS (2010)
Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection
Florence Faurez et al.
VACCINE (2010)
Engineering of bacterial strains and vectors for the production of plasmid DNA
Diana M. Bower et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production
James A. Williams et al.
BIOTECHNOLOGY ADVANCES (2009)
Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
Mei Huang et al.
CIRCULATION (2009)
Gene Transfer to Mouse Heart and Skeletal Muscles Using a Minicircle Expressing Human Vascular Endothelial Growth Factor
Sofia Stenler et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Structural instability of plasmid biopharmaceuticals: challenges and implications
Pedro H. Oliveira et al.
TRENDS IN BIOTECHNOLOGY (2009)
Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system
Jeremy Luke et al.
VACCINE (2009)
Sustained Transgene Expression Using MAR Elements
Niamh Harraghy et al.
CURRENT GENE THERAPY (2008)
Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences
A. M. Miller et al.
GENE THERAPY (2008)
Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector
O. Argyros et al.
GENE THERAPY (2008)
Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene
Xichen Zhang et al.
HUMAN GENE THERAPY (2008)
Evaluation of gene promoters for liver expression by hydrodynamic gene transfer
Andrew T. Nguyen et al.
JOURNAL OF SURGICAL RESEARCH (2008)
High Frequency Plasmid Recombination Mediated by 28 bp Direct Repeats
Sofia C. Ribeiro et al.
MOLECULAR BIOTECHNOLOGY (2008)
Sleeping Beauty vector system moves toward human trials in the United States
David A. Williams
MOLECULAR THERAPY (2008)
Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation
Zhi-Ying Chen et al.
MOLECULAR THERAPY (2008)
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Stephen C. Hyde et al.
NATURE BIOTECHNOLOGY (2008)
In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence
Guobjorg Olafsdottir et al.
ACTA VETERINARIA SCANDINAVICA (2008)
Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state
Brian D. Brown et al.
NATURE BIOTECHNOLOGY (2007)
Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo
Efren Riu et al.
MOLECULAR THERAPY (2007)
Identification and characterization of IS1 transposition in plasmid amplification mutants of E-coli clones producing DNA vaccines
Kristala L. Jones Prather et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2006)
Minicircle-IFNγ induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma
Jiangxue Wu et al.
CLINICAL CANCER RESEARCH (2006)
Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin
M Suzuki et al.
JOURNAL OF VIROLOGY (2006)
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo
ZY Chen et al.
HUMAN GENE THERAPY (2005)
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo
ZY Chen et al.
GENE THERAPY (2004)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines
JR Cooke et al.
JOURNAL OF BIOTECHNOLOGY (2004)
Minicircle DNA immobilized in bacterial ghosts: In vivo production of safe non-viral DNA delivery vehicles
W Jechlinger et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2004)
Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo
ZY Chen et al.
MOLECULAR THERAPY (2003)
Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature
JL Young et al.
GENE THERAPY (2003)
DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice
L López-Fuertes et al.
VACCINE (2002)
Homogeneous expression of the PBAD promoter in Escherichia coli by constitutive expression of the low-affinity high-capacity AraE transporter
A Khlebnikov et al.
MICROBIOLOGY-SGM (2001)
CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved
R Rankin et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2001)
High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter
NS Yew et al.
MOLECULAR THERAPY (2001)
An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy
BW Bigger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide
R Schirmbeck et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
A regulated, NFκB-assisted import of plasmid DNA into mammalian cell nuclei
A Mesika et al.
MOLECULAR THERAPY (2001)
Interruption of coding sequences by heterologous introns can enhance the functional expression of recombinant genes
A Lacy-Hulbert et al.
GENE THERAPY (2001)
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells:: A first clinical phase I/II trial
B Wittig et al.
HUMAN GENE THERAPY (2001)
The role of CpG in DNA vaccines
MJ McCluskie et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2000)
Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix
A Baiker et al.
NATURE CELL BIOLOGY (2000)
Share Paper
